Cervical cancer
Results
Phase 3
This trial looked at pembrolizumab for cervical cancer that had spread into the surrounding tissue and had a high risk of coming back. It was for people who had recently been diagnosed and had not had treatment yet.
People could join the trial between 2020 and 2022. The team published the results in 2024 and 2025.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 9 June 2020
Recruitment end: 15 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Susan Lalondrelle
Merck Sharp & Dohme Ltd
Last reviewed: 23 Jul 2026
CRUK internal database number: 17441
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
